Celldex Announces $300M Equity Offering; Shares Slip
Celldex Therapeutics Inc announced an underwritten public offering of 10,345,000 common shares priced at $29.00 each, sparking a 2.7% decline in the company's stock on Thursday. The company granted underwriters a 30-day option to purchase an additional 1,551,750 shares and said it expects gross proceeds of roughly $300 million before fees. Proceeds…